Holds one active US DMF and 2 valid CEPs for teriflunomide, filing since 2016. Its 2025 FDA inspection closed as VAI, and its GMP is recognised in 18 markets.
Holds one active US DMF and 2 valid CEPs for teriflunomide, filing since 2016. Its 2025 FDA inspection closed as VAI, and its GMP is recognised in 18 markets.
Holds one active US DMF and one valid CEP for teriflunomide, filing since 2014. Its 2025 FDA inspection closed as VAI, and its GMP is recognised in 26 markets.
Holds one active US DMF and one valid CEP for teriflunomide, filing since 2016. Its 2025 FDA inspection closed as VAI, and its GMP is recognised in 29 markets.
Holds one active US DMF and one valid CEP for teriflunomide, filing since 2015. Its 2019 FDA inspection closed as VAI, and its GMP is recognised in 2 markets.
Holds 2 active US DMFs and one valid CEP for teriflunomide, filing since 2015. Its 2025 FDA inspection closed as NAI, and its GMP is recognised in 1 market.
Holds one active US DMF and one valid CEP for teriflunomide, filing since 2017. Its 2025 FDA inspection closed as NAI, and its GMP is recognised in 1 market.
Holds one active US DMF and one valid CEP for teriflunomide, filing since 2016. Its 2022 FDA inspection closed as VAI.
Holds one valid CEP for teriflunomide, filing since 2024. Its 2026 FDA inspection closed as VAI, and its GMP is recognised in 13 markets.
Holds 2 active US DMFs for teriflunomide, filing since 2016. Its 2025 FDA inspection closed as VAI, and its GMP is recognised in 15 markets.
Holds one active US DMF for teriflunomide, filing since 2016. Its 2025 FDA inspection closed as VAI, and its GMP is recognised in 25 markets.
Holds one active US DMF for teriflunomide, filing since 2015. Its 2024 FDA inspection closed as VAI, and its GMP is recognised in 1 market.
Holds one active US DMF for teriflunomide, filing since 2015. Its 2025 FDA inspection closed as NAI.
Holds one active US DMF for teriflunomide, filing since 2016. Its 2025 FDA inspection closed as VAI, and its GMP is recognised in 3 markets.
Holds one active US DMF for teriflunomide, filing since 2015. Its 2023 FDA inspection closed as VAI.
Holds one active US DMF and one valid CEP for teriflunomide, filing since 2016. Its 2025 FDA inspection closed as VAI.
Holds one active US DMF for teriflunomide, filing since 2021. Its 2019 FDA inspection closed as VAI, and its GMP is recognised in 1 market.
Registered with SFDA (Saudi Arabia) for teriflunomide. Its 2022 FDA inspection closed as VAI, and its GMP is recognised in 40 markets.
Holds one active US DMF for teriflunomide, filing since 2021. Its 2025 FDA inspection closed as VAI, and its GMP is recognised in 1 market.
Holds one active US DMF for teriflunomide, filing since 2016. Its 2024 FDA inspection closed as VAI.
Holds one valid CEP for teriflunomide, filing since 2024.
The names are listed below. Ask Fred about the filings, inspection history and GMP certificates on record for each manufacturer.
The order is set by active filings weighted by regulator, inspection outcomes and their recency, breadth of GMP recognition, and evidence of real exports, less any open risk flags. Every factor appears on the card it produced. Read the full method.
Ask Fred which manufacturers are on record for teriflunomide and what filings they hold.
Chat with Fred, your AI analyst